Nationwide Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-173,157
| Closed | -$26.3M | – | 2054 |
|
|
2017
Q3 | $26.3M | Buy |
173,157
+56,646
| +49% | +$8.61M | 0.1% | 215 |
|
|
2017
Q2 | $15M | Sell |
116,511
-5,407
| -4% | -$697K | 0.06% | 450 |
|
|
2017
Q1 | $13.3M | Sell |
121,918
-99,438
| -45% | -$10.9M | 0.05% | 510 |
|
|
2016
Q4 | $16.3M | Sell |
221,356
-40,925
| -16% | -$3.01M | 0.07% | 386 |
|
|
2016
Q3 | $22.9M | Buy |
262,281
+154,249
| +143% | +$13.5M | 0.1% | 240 |
|
|
2016
Q2 | $9.29M | Buy |
108,032
+8,421
| +8% | +$724K | 0.04% | 609 |
|
|
2016
Q1 | $7.92M | Sell |
99,611
-33,234
| -25% | -$2.64M | 0.03% | 695 |
|
|
2015
Q4 | $16.7M | Sell |
132,845
-145,545
| -52% | -$18.3M | 0.07% | 353 |
|
|
2015
Q3 | $29M | Sell |
278,390
-9,280
| -3% | -$966K | 0.13% | 166 |
|
|
2015
Q2 | $35.5M | Buy |
287,670
+2,031
| +0.7% | +$251K | 0.15% | 141 |
|
|
2015
Q1 | $33.7M | Sell |
285,639
-39,078
| -12% | -$4.61M | 0.14% | 159 |
|
|
2014
Q4 | $38.6M | Buy |
324,717
+20,724
| +7% | +$2.46M | 0.16% | 129 |
|
|
2014
Q3 | $34.1M | Sell |
303,993
-26,123
| -8% | -$2.93M | 0.14% | 151 |
|
|
2014
Q2 | $31.3M | Buy |
330,116
+65,841
| +25% | +$6.23M | 0.13% | 186 |
|
|
2014
Q1 | $18.7M | Sell |
264,275
-5,854
| -2% | -$414K | 0.09% | 289 |
|
|
2013
Q4 | $20.1M | Sell |
270,129
-23,687
| -8% | -$1.76M | 0.08% | 286 |
|
|
2013
Q3 | $22.3M | Sell |
293,816
-189,679
| -39% | -$14.4M | 0.1% | 237 |
|
|
2013
Q2 | $38.6M | Buy |
+483,495
| New | +$38.6M | 0.2% | 84 |
|